V
Vanessa Escuret
Researcher at Claude Bernard University Lyon 1
Publications - 36
Citations - 989
Vanessa Escuret is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Neuraminidase & Influenza A virus. The author has an hindex of 16, co-authored 31 publications receiving 800 citations. Previous affiliations of Vanessa Escuret include École normale supérieure de Lyon & University of Lyon.
Papers
More filters
Journal ArticleDOI
Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France
Jean-Sébastien Casalegno,Michèle Ottmann,M. Bouscambert Duchamp,Vanessa Escuret,Geneviève Billaud,Emilie Frobert,F. Morfin,Bruno Lina +7 more
TL;DR: The hypothesis that HRV infections can reduce the probability of A(H1N1) infection is supported, as viral interference between respiratory viruses could have affected the spread of the H 1N1 viruses and delayed the influenza pandemic at the beginning of autumn in France.
Journal ArticleDOI
Pandemic A(H1N1)2009 influenza virus detection by real time RT‐PCR : is viral quantification useful?
M. Bouscambert Duchamp,Jean-Sébastien Casalegno,Y. Gillet,Emilie Frobert,E. Bernard,Vanessa Escuret,Geneviève Billaud,Martine Valette,Etienne Javouhey,Bruno Lina,D. Floret,F. Morfin +11 more
TL;DR: This study shows that real time RT-PCR targeting the matrix gene is a reliable tool for quantification of type A influenza virus but emphasises the need for sample quality control assessment through cellular gene quantification for reliable estimation of the viral load.
Journal ArticleDOI
Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.
Vanessa Escuret,Emilie Frobert,M. Bouscambert-Duchamp,M. Sabatier,Isidore Grog,Martine Valette,Bruno Lina,F. Morfin,Olivier Ferraris +8 more
TL;DR: Resistant influenza strains to NAIs are circulating at a stable and low level of 1% since the introduction of NAIs in clinical practice.
Journal ArticleDOI
Performance Assessment of SARS-CoV-2 PCR Assays Developed by WHO Referral Laboratories.
Sibyle Etievant,Antonin Bal,Vanessa Escuret,Karen Brengel-Pesce,Maude Bouscambert,Valérie Cheynet,Laurence Generenaz,Guy Oriol,Grégory Destras,Geneviève Billaud,Laurence Josset,Emilie Frobert,Florence Morfin,Alexandre Gaymard +13 more
TL;DR: Comparing the sensitivity and specificity of different RT-PCR assays using SARS-CoV-2 cell culture supernatants and clinical respiratory samples found RdRp Institut Pasteur (IP2, IP4, N China CDC, and N1 US CDC) to be the most sensitive assays.